Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Lykis Limited (LYKISLTD.BO)
Mumbai, MH, IN
Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides baby deos, body scrubs, baby ranges, biscuits, jellies, body lotions, roll-ons, shampoos, peel-off masks, perfumes, body mists, body creams, pharmas, soaps, charcoal ranges, hair colors, creams, toothpastes, lotions, body oils, biscuits and cookies, liquors, deos, coffees, confectioneries, hot pots, foods, stationary, and beverages. It also offers raw materials, such as Cocoa Butter Refined, Hard Paraffin Wax, Calcium Carbonate, Raw Talc, Extra Neutral Alcohol, Almond Oil, Cetostearyl Alcohol, Glycerin, Cetyl Alcohol, Hydroquinone, Pine Oil, D-Panthenol, light liquid paraffin, as well as food products. In addition, it sells pharma products, as well as commodities. It sells its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Lyfresh, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brand names. The company was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. Lykis Limited was incorporated in 1984 and is headquartered in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.55% | +0.22% | +1.39% | -11.76% | +46.67% | +16.51% | +27.87% | -58.49% | +28.13% | -18.52% | +735.19% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Household & Personal Products: +3.3%+32.1% ★ Q1'26: +136.6% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+147.4% ★ Q1'26: +388.6% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-9.5% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+3.1% Q1'26: +3.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+7.7% Q1'26: +9.5% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.3% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×7.82× Q1'26: 5.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 4/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-25 | B- | 3/5 | 1/5 | 4/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | B | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 2/5 | 4/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 4/5 | 1/5 | 4/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Nadir Umedali Dhrolia | MD & Executive Chairman | 8M | male |
| Shrigopal Kandoi | Chief Financial Officer | 4M | male |
| Darshana Avadhoot Sawant | Company Secretary & Compliance Officer | 1M | female |
| Anil Kumar | Chief Human Resource Officer | — | male |
| Hitesh Mehra | Vice President of Sales & Marketing | — | male |
| Samir Dhrolia | Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LYKISLTD.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
